Aug 10, 2026 07:00AM

Aug 4, 2026 07:00AM

Jul 6, 2026 07:00AM

May 20, 2026 07:00AM

Mar 25, 2026 07:00AM

Mar 23, 2026 07:00AM

Oct 15, 2025 07:00AM Algernon Pharmaceuticals changes name to Algernon Health

Oct 15, 2025 07:00AM

Sep 25, 2025 07:00AM

Sep 4, 2025 07:00AM

Sep 4, 2025 07:00AM

May 13, 2025 07:00AM

Jul 16, 2024 08:00AM

Mar 27, 2024 12:04PM Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position

Nov 22, 2023 07:00AM

Jun 27, 2023 07:00AM

Jan 9, 2023 07:00AM

Dec 5, 2022 07:00AM

Sep 19, 2022 07:00AM

Sep 1, 2022 07:00AM

Jul 18, 2022 08:00AM Algernon Pharmaceuticals Hits Co-Primary Endpoint in its Phase 2 Study of Ifenprodil for Idiopathic Pulmonary Fibrosis and Chronic Cough

Feb 23, 2022 07:00AM

Jan 14, 2022 08:15AM

328,147 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All